Researcher Profile and Settings

Researcher

• Name

  Matsuyama Toshiyuki

Profile and Settings

• Name

  Toshiyuki, Matsuyama

Affiliation

• Gunma University, Assistant Professor

Degree

• D.M.Sci.

Research Activities

Published Papers

• Interleukin‐8 produced by T cells is under the control of dopamine signaling., Matsuyama T, Kawano M, Takagi R, Nakagome K, Chikamatsu K, Matsushita S., 2018, Clinical and Experimental Neuroimmunology, 9, 251, 257
• 血管内治療で救命した顎動静脈瘻破裂症例 , 高橋 克昌,相馬 眞祈,松山 敏之,工藤 毅,近松 一朗 , Dec. 2016, 119, 12, 1516-1522

  DOI
• C1-inactivatorが著効した血管性浮腫の1例 , 多田 紘恵,松山 敏之,工藤 毅,近松 一朗 , 2017, 120, 3, 217-223

  DOI
• How to use NSAIDs for patients with nasal polyps, Matsuyama Toshiyuki;Tada Hiroe;Chikamatsu Kazuaki, 2019, Journal of Japan Society of Immunology & Allergology in Otolaryngology, 37, 3, 229, 232
• Human Papillomavirus-related Sinonasal Carcinoma: Report of Two Cases, Matsuyama Toshiyuki;Shimoda Yuki;Ida Shota;Chikamatsu Kazuaki, 2020, Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 59, 4, 363, 369

  DOI
• Effect of Treatment with Dupilumab for Eosinophilic Chronic Rhinosinusitis, Matsuyama Toshiyuki;Takahashi Hideyuki;Tada Hiroe;Nagata Yurino;Chikamatsu Kazuaki, Jun. 2021, Nippon Jibiinkoka Gakkai Kaiho, 124, 6, 884, 889

  DOI
• シングルセル解析を用いたdupilumab投与前後での末梢血リンパ球の網羅的プロファイリング, ;, Sep. 2021, 60, 3, 373
• dupilumab治療における末梢血リンパ球の網羅的プロファイリングと新規バイオマーカーの開発, ;;;;, Mar. 2022, 2回, 140
• A Case of Maxillary Arteriovenous Fistula Rupture Treated by Vascular Interventional Radiology, Takahashi Katsumasa;Soma Maori;Matsuyama Toshiyuki;Kudo Takeshi;Chikamatsu Kazuaki, 2016, Nippon Jibiinkoka Gakkai Kaiho, 119, 12, 1516, 1522

  DOI
• A Case Report of Acute Angioedema that Showed Dramatic Response to Administration of a C1-inactivator, Tada Hiroe;Matsuyama Toshiyuki;Kudo Takeshi;Chikamatsu Kazuaki, 2017, Nippon Jibiinkoka Gakkai Kaiho, 120, 3, 217, 223

  DOI
• Validity of Treatment for Patients with Head and Neck Squamous Cell Carcinoma with Distant Metastasis Detected at the First Examination, Takahashi Katsumasa;Nishioka Yuki;Ida Shota;Kuwabara Yuki;Matsuyama Toshiyuki;Okamoto Ayako;Kuwabara Mikio;Shino Masato;Nikkuni Osamu;Kudo Takeshi;Takayasu Yukihiro;Chikamatsu Kazuaki, Oct. 2018, Nippon Jibiinkoka Gakkai Kaiho, 121, 10, 1288, 1293

  DOI
• ドーパミンD2様受容体アゴニストによる好中球性炎症の抑制, ;;, Jun. 2018, 36, 2, 93
• T細胞からのIL-8産生はドーパミンD2様受容体アゴニストによって抑制される, ;;;;, May 2018, 67, 4-5, 675
• dupilumab治療における末梢血リンパ球の網羅的プロファイリングと新規バイオマーカーの開発, ;;;;, Mar. 2022, 2回, 140
• スギ舌下免疫療法による臨床効果とQOL及び満足度との関係, ;;;, Jul. 2022, 61, 2, 310
• 頭頸部扁平上皮癌におけるtissue resident memory T cellについての検討, ;;;;, Mar. 2022, 2回, 183
• 哺乳障害を契機に発見された上咽頭奇形腫の一例, ;;, Apr. 2022, 125, 4, 806
• Two Cases of Angioedema Developing During Angiotensin II Receptor Antagonist Therapy, Uchida Miho;Matsuyama Toshiyuki;Chikamatsu Kazuaki, 2022, Practica Oto-Rhino-Laryngologica, 115, 1, 59, 65

  DOI
• 血管内治療で救命した顎動静脈瘻破裂症例, ;;;;, Dec. 2016, 119, 12, 1516
• Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis., Tsurumaki Hiroaki;Matsuyama Toshiyuki;Ezawa Kazuma;Koga Yasuhiko;Yatomi Masakiyo;Aoki-Saito Haruka;Chikamatsu Kazuaki;Hisada Takeshi, Jul. 2019, Medicina (Kaunas, Lithuania), 55, 7

  DOI
• Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma., Tada Hiroe;Takahashi Hideyuki;Kawabata-Iwakawa Reika;Nagata Yurino;Uchida Miho;Shino Masato;Ida Shota;Mito Ikko;Matsuyama Toshiyuki;Chikamatsu Kazuaki, Dec. 2020, Scientific reports, 10, 1

  DOI
• The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma., Tada Hiroe;Takahashi Hideyuki;Ida Shota;Mito Ikko;Matsuyama Toshiyuki;Chikamatsu Kazuaki, Anticancer research, 41, 2

  DOI
• Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma., Tada Hiroe;Nagata Yurino;Takahashi Hideyuki;Matsuyama Toshiyuki;Ida Shota;Mito Ikko;Chikamatsu Kazuaki, May 2021, Molecular and clinical oncology, 15, 1

  DOI
• Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab., Tada Hiroe;Takahashi Hideyuki;Yamada Kanae;Masuda Kei;Nagata Yurino;Uchida Miho;Shino Masato;Ida Shota;Mito Ikko;Matsuyama Toshiyuki;Oyama Tetsunari;Tatematsu Ken-Ichiro;Sezutsu Hideki;Takeda Shigeki;Chikamatsu Kazuaki, Aug. 2021, Cancer immunology, immunotherapy : CII, 71, 4

  DOI
• Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma., Takahashi Hideyuki;Sakakura Koichi;Ida Shota;Kawabata-Iwakawa Reika;Matsuyama Toshiyuki;Tada Hiroe;Mito Ikko;Chikamatsu Kazuaki, Nov. 2021, Cancer science, 113, 1

  DOI
• Human papillomavirus(HPV)56型が検出されたHPV-related multiphenotypic sinonasal carcinomaの1例, ;;;;, Mar. 2020, 109, 1, 400
• アンジオテンシンII受容体拮抗薬内服中に発症した血管性浮腫の2例, ;;, Jan. 2022, 115, 1, 59
• Nivolumab投与による抗腫瘍免疫応答の誘導と治療耐性についての検討, ;;;;;;;, Apr. 2022, 125, 4, 758
• 特発性髄液耳漏の1例, ;;;, Jun. 2022, 補冊159, 116
• ニボルマブ治療における頭頸部扁平上皮癌患者の末梢血Tリンパ球の動態と予後についての検討, ;;;;, Mar. 2022, 2回, 87
• Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis, Tsurumaki, Hiroaki;Matsuyama, Toshiyuki;Ezawa, Kazuma;Koga, Yasuhiko;Yatomi, Masakiyo;Aoki-Saito, Haruka;Chikamatsu, Kazuaki;Hisada, Takeshi, 2019, MEDICINA-LITHUANIA, 55, 7

  DOI
• Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Kawabata-Iwakawa, Reika;Nagata, Yurino;Uchida, Miho;Shino, Masato;Ida, Shota;Mito, Ikko;Matsuyama, Toshiyuki;Chikamatsu, Kazuaki, 2020, SCIENTIFIC REPORTS, 10, 1

  DOI
• The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Ida, Shota;Mito, Ikko;Matsuyama, Toshiyuki;Chikamatsu, Kazuaki, 2021, ANTICANCER RESEARCH, 41, 2, 885, 893

  DOI
• Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab, Tada, Hiroe;Takahashi, Hideyuki;Yamada, Kanae;Masuda, Kei;Nagata, Yurino;Uchida, Miho;Shino, Masato;Ida, Shota;Mito, Ikko;Matsuyama, Toshiyuki;Oyama, Tetsunari;Tatematsu, Ken-Ichiro;Sezutsu, Hideki;Takeda, Shigeki;Chikamatsu, Kazuaki, 2022, CANCER IMMUNOLOGY IMMUNOTHERAPY, 71, 4, 851, 863

  DOI
• Circulating naive and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma, Takahashi, Hideyuki;Sakakura, Koichi;Ida, Shota;Kawabata-Iwakawa, Reika;Matsuyama, Toshiyuki;Tada, Hiroe;Mito, Ikko;Chikamatsu, Kazuaki, 2022, CANCER SCIENCE, 113, 1, 53, 64

  DOI
• Diffuse large B-cell lymphoma of the pterygopalatine fossa with multiple cranial nerve palsies, Ida, Shota;Matsuyama, Toshiyuki;Ishizawa, Kunihiko;Nagashima, Kazuaki;Yoshida, Yuka;Chikamatsu, Kazuaki, 2021, B-ENT, 17, 3, 196, 200

  DOI
• Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment, Matsuyama, Toshiyuki;Takahashi, Hideyuki;Tada, Hiroe;Chikamatsu, Kazuaki, 2022, AMERICAN JOURNAL OF RHINOLOGY & ALLERGY

  DOI
• 頭頸部扁平上皮癌患者の循環癌細胞におけるPD-L1/PD-L2分子の発現, ;;;;, Jun. 2018, 36, 2, 131
• 好酸球性副鼻腔炎に対するbenralizumabの効果, ;;, Sep. 2018, 57, 3, 418
• 気管支温熱療法後の好酸球増多を伴う気管支喘息増悪と好酸球性副鼻腔炎に対してベンラリズマブが著効した1例, ;;;;;;;;;, Mar. 2019, 8, 増刊, 279
• ローゼンミューラー窩に発生した放線菌症の1例, ;;;, Apr. 2019, 122, 4, 699
• 重症気管支喘息に合併する好酸球性副鼻腔炎に対してbenralizumabが著効した1例, ;;, Jun. 2019, 37, 2, 136
• 鼻茸患者に対するNSAIDsの取り扱い方, ;;, Sep. 2019, 37, 3, 229
• 蝶形骨洞腫瘍の鑑別におけるFDG-PET検査の有用性, ;;;, Sep. 2019, 58, 3, 513
• Human papillomavirus(HPV)56型が検出されたHPV-related multiphenotypic sinonasal carcinomaの1例, ;;;;;;, Apr. 2020, 37, 2, 168
• 重症気管支喘息に合併する好酸球性副鼻腔炎に対してデュピルマブが奏功した一例, ;;;, Sep. 2020, 123, 4, 1119
• Human papillomavirus(HPV)56型が検出されたHPV-related multiphenotypic sinonasal carcinomaの1例, ;;;;, Mar. 2020, 109, 1, 400
• 好酸球性副鼻腔炎に対する生物学的製剤の治療効果とその将来展望, ;, Jan. 2021, 41, 1, 32
• 好酸球性副鼻腔炎に対するdupilumabの臨床効果, ;, Dec. 2020, 59, Suppl., S27
• アンジオテンシンII受容体拮抗薬(ARB)内服中に発症した血管性浮腫の2例, ;;;, Dec. 2020, 補冊155, 133
• Human papillomavirus(HPV)関連鼻副鼻腔癌の2症例, ;;;, Dec. 2020, 59, 4, 363
• 末梢血循環癌細胞における遺伝子発現とニボルマブの治療効果の検討, ;;;;;;;;, Apr. 2021, 124, 4, 586
• TCGAデータベースを用いた頭頸部癌における解糖系遺伝子発現の網羅的解析, ;;;;;, Apr. 2021, 124, 4, 594
• 好酸球性副鼻腔炎診療における現在の問題点の検討, ;;;;;;;, Apr. 2021, 124, 4, 600
• 多発脳神経麻痺を来した翼口蓋窩原発びまん性大細胞型B細胞リンパ腫の一例, ;;, Apr. 2021, 124, 4, 641
• 抗IL-5製剤投与後の好酸球性副鼻腔炎患者の鼻茸中好酸球数の評価, ;;;, Dec. 2020, 38, 4, 152
• 好酸球性副鼻腔炎に対するdupilumabの臨床効果, ;;;;, Jun. 2021, 124, 6, 884
• ニボルマブ治療における末梢血循環癌細胞のバイオマーカーとしての意義についての検討, ;;;, May 2021, 1回, 130
• Dupilumab投与前後の鼻副鼻腔臨床所見と末梢血中好酸球の変動についての検討, ;;;, May 2021, 1回, 162
• 好酸球性副鼻腔炎・中耳炎(生物学的製剤)　Dupilumabが投与されたType2気道炎症の臨床所見と末梢血好酸球の変動についての検討, ;, Aug. 2021, 70, 6-7, 819
• ECRS併存重症気管支喘息において抗IL-5/IL-5Rα抗体から抗IL-4Rα抗体に切り替えた症例の検討, ;;;;;;;;;;;;, Aug. 2021, 70, 6-7, 854
• 好酸球性多発血管炎性肉芽腫症にアレルギー性肺アスペルギルス症と好酸球性副鼻腔炎を同時発症した一例, ;;;;;;;;;;;;;;, Aug. 2021, 70, 6-7, 860
• シングルセル解析を用いたdupilumab投与前後での末梢血リンパ球の網羅的プロファイリング, ;, Sep. 2021, 60, 3, 373
• アンジオテンシンII受容体拮抗薬内服中に発症した血管性浮腫の2例, ;;, Jan. 2022, 115, 1, 59
• Nivolumab投与による抗腫瘍免疫応答の誘導と治療耐性についての検討, ;;;;;;;, Apr. 2022, 125, 4, 758
• 哺乳障害を契機に発見された上咽頭奇形腫の一例, ;;, Apr. 2022, 125, 4, 806
• 特発性髄液耳漏の1例, ;;;, Jun. 2022, 補冊159, 116
• ニボルマブ治療における頭頸部扁平上皮癌患者の末梢血Tリンパ球の動態と予後についての検討, ;;;;, Mar. 2022, 2回, 87
• 頭頸部扁平上皮癌におけるtissue resident memory T cellについての検討, ;;;;, Mar. 2022, 2回, 183

MISC

• C1-inactivatorが著効した血管性浮腫の1例, 多田 紘恵,松山 敏之,工藤 毅,近松 一朗, 2017, 120, 3, 217, 223

  DOI
• 血管内治療で救命した顎動静脈瘻破裂症例, 高橋 克昌,相馬 眞祈,松山 敏之,工藤 毅,近松 一朗, 2016, 119, 12, 1516, 1522

  DOI